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ORIGINAL INVESTIGATION
Alterations in heart rate variability 
during everyday life are linked to insulin 
resistance. A role of dominating sympathetic 
over parasympathetic nerve activity?
Maria K. Svensson1*, Stina Lindmark2, Urban Wiklund3, Peter Rask4, Marcus Karlsson3, Jan Myrin4, Joel Kullberg5, 
Lars Johansson5 and Jan W. Eriksson1
Abstract 
Aims: To evaluate the role of the autonomic nervous system (ANS) in the development of insulin resistance (IR) and 
assess the relationship between IR and activity of ANS using power spectrum analysis of heart rate variability (HRV).
Subjects and methods: Twenty-three healthy first-degree relatives of patients with type 2 diabetes (R) and 24 
control subjects without family history of diabetes (C) group-matched for age, BMI and sex were included. Insulin 
sensitivity (M value) was assessed by hyperinsulinemic (56 mU/m2/min) euglycemic clamp. Activity of the ANS was 
assessed using power spectrum analysis of HRV in long-term recordings, i.e., 24-h ECG monitoring, and in short-term 
recordings during manoeuvres activating the ANS. Computed tomography was performed to estimate the amount 
and distribution of abdominal adipose tissue.
Results: Insulin sensitivity (M value, mg/kg lbm/min) did not differ significantly between the R and C groups. Total 
spectral power (Ptot) and very low-frequency (PVLF) power was lower in R than C during 24 h ECG-recordings (p = 0.02 
and p = 0.03). The best fit multiple variable linear regression model (r2 = 0.37, p < 0.001 for model) indicated that 
body composition (BMI) and long-term low to high frequency (LF/HF) power ratio (std β = −0.46, p = 0.001 and std 
β = −0.28, p = 0.003, respectively) were significantly and independently associated with the M value.
Conclusion: Altered heart rate variability, assessed by power spectrum analysis, during everyday life is linked to insu-
lin resistance. The data suggest that an increased ratio of sympathetic to parasympathetic nerve activity, occurring via 
both inherited and acquired mechanisms, could potentially contribute to the development of type 2 diabetes.
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Background
Insulin resistance (IR) is associated with future risk of 
developing type 2 diabetes (T2D). As a group, relatives 
of patients with T2D are more insulin-resistant and also 
have an increased risk of developing T2D later in life but 
there is an overlap in IR when compared to subjects with-
out a family history of T2D [1]. The pathophysiological 
mechanism(s) causing IR are still not fully understood, but 
candidate genes related to cellular insulin action may be 
potential contributors [1–3]. The fact that cellular insulin 
resistance may be reversible [4, 5] indicates that the in vivo 
milieu is of importance and for example enhanced activ-
ity in the sympathetic nervous system (SNS) has been sug-
gested as a mediator of IR [6]. Elevated activity of the SNS 
has thus been proposed as a causal factor in the “insulin 
resistance syndrome” [7]. Not only an elevated activity of 
the SNS, but also an attenuated activity in the parasympa-
thetic nervous system could contribute and we have pre-
viously reported an association between IR and reduced 
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parasympathetic-to-sympathetic activity in non-diabetic 
subjects [8]. This is in line with previous findings that non-
diabetic offsprings of patients with T2D have an altered 
response to acute hyperinsulinemia with an increase in 
total spectral power and low-frequency to high-frequency 
(LF/HF) power ratio and a decrease in high-frequency 
power HRV [9]. A link between HRV and IR has also been 
found in other populations [10–12].
The main objective of this study was to further assess 
the relationship between IR and activity of the ANS using 
power spectrum analysis of HRV analysed from long-
term, 24-h ECG-recordings, obtained during normal eve-
ryday life. This was done in healthy non-diabetic subjects. 
We also compared first-degree relatives of patients with 
T2D with subjects without a family history of T2D. In 
addition, power spectrum analysis of HRV was assessed 
using short-term recordings both during resting condi-
tions and during manoeuvres that activates the sympa-
thetic or the parasympathetic nervous system [8, 13].
Subjects and methods
Subjects
Forty-seven healthy, non-diabetic subjects were enrolled. 
Twenty-three subjects had either two first-degree or one 
first-degree plus at least two second-degree relatives with 
T2D (R) and 24 subjects had no known family history of 
T2D (C). The R and C groups were group-matched for 
sex, age and BMI. Seven of the enrolled subjects had taken 
part in a previous study [8] and were thus assessed at two 
different time-points in years 1997–98 and 2004, mean 
6  years apart. The subjects were recruited by advertise-
ment in the local newspaper. The participants were healthy 
and had no signs of diabetes or pre-diabetes, systemic 
chronic diseases, infections or inflammation as assessed 
by medical history and blood chemistry. Informed consent 
was obtained from all subjects and the study protocol was 
approved by the Ethical Committee of Umeå University.
Protocol
The examinations were performed at four different visits 
within 4 weeks and in the following sequence: blood sam-
pling, OGTT and questionnaire, euglycemic hyperinsu-
linemic clamp, short- and long-term HRV and computed 
tomography (CT). All examinations except the long-term 
HRV and the CT were performed in the morning after 
an overnight fast (>10  h). Lean body mass was deter-
mined by an bioelectrical impedance analysis method 
(BIA 101-Fitness RJL Systems, Detroit, MI, USA) [14]. 
Oral glucose tolerance test (OGTT) was performed with 
the subjects in the sitting position when ingestion of 75 g 
glucose in a liquid solution and venous blood samples for 
analyses of blood glucose and serum insulin were then 
obtained in the fasting state and after 120 min.
Questionnaire to assess self‑rated stress behaviour
The Everyday Life Stress Scale instrument [15] was 
used to assess the level of self-rated stress behaviour. 
The instrument consists of two major themes, i.e., time 
urgency/impatience and easily aroused irritation/hos-
tility. The responses to the 20 different statements were 
given using a four-point scale (0–3) where higher scores 
indicate more stressful reactions.
Euglycemic hyperinsulinemic clamp
Insulin sensitivity was assessed using the euglyce-
mic hyperinsulinemic clamp technique as previously 
described [8]. The rate of glucose infusion served as a 
measure of insulin sensitivity and the M value was cal-
culated by dividing the amount of glucose infused during 
the last 60 min (steady state) of the clamp by lean body 
mass (mg/lbm kg/min). The insulin sensitivity index (ISI) 
was calculated by dividing the M value by the mean insu-
lin concentration during the same period of the clamp 
(100 × mg/kg/min/[mU/L]) [16].
Computed tomography (CT)
Forty-four of the 47 subjects (23 R, 21 C) did the per-
formed CT examinations/scans and they were exam-
ined in the evening (non-fasting state) using the Siemens 
Somatom Plus 4 CT system, version VB 40c (Siemens, 
Erlangen, Germany), 140  kV, FoV 352, mAs 180, slice 
thickness 10  mm, fixed filtration. The CT-scans were 
obtained in the lumbar region, at the L2 and L4 level. 
Adipose tissue was determined as Hounsfield values 
between −190 and −30 HU from the L4 slice. Abdominal 
subcutaneous (SAT) and visceral adipose tissue (VAT) 
was separated by manual segmentation [17] using soft-
ware ImageJ [18]. Fat infiltration of the liver (liver fat) 
was determined from the L2 slice. Liver tissue was also 
segmented manually and the mean Hounsfield value was 
used.
Heart rate variability (HRV) assessments
A short-term recording of HRV was performed as previ-
ously described in detail [19]. Power spectrum analysis 
was performed using auto-regressive modelling of lin-
early detrended heart rate data [20].
A long-term HRV recording was performed during nor-
mal day-time activities, night-time and sleep. We used 
24-h ECG monitoring (Holter), with a digital recorder 
unit (Braemer DL 700, Braemer Inc. Burnsville, MN, 
USA) and the recording was then analysed using a PC-
based Holter system (Aspect Holter System, GE Health-
care, Borlänge, Sweden). After manual editing, R–R 
intervals and the classification of heartbeats were analysed 
using Matlab (Mathworks Inc., Natick, Mass., USA) [21]. 
Undetected ectopic beats were removed by an algorithm 
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for automatic filtering [21, 22]. Power spectrum analysis 
was performed by fast Fourier transformation (FFT) of 
R–R intervals related to normal interbeat intervals [21]. 
HRV was only analysed in recordings with more than 
70  % of registration time (24  h). Five subjects were not 
included in the HRV analyses, three had recordings <70 % 
of the registration time, one subject had atrial fibrillation 
and in one subject the technical quality of the recording 
was poor and not sufficient to support the analysis. Taken 
together power spectrum analysis of long-term HRV was 
performed in 43 subjects (21 R and 22 C). The HRV indi-
ces (see Table 2) were calculated as average data over 24 h.
Power spectrum analysis was performed as total spec-
tral power (Ptot) and the power of the very low-frequency 
(VLF; 0.003–0.04 Hz), low-frequency (LF; 0.04–0.15 Hz) 
and high-frequency (HF; 0.15–0.50 Hz). The components 
were calculated and log-transformed. The variability of 
the HF component is mainly mediated by parasympa-
thetic activity, whereas the LF fluctuations are mediated 
by both sympathetic and parasympathetic activity [23]. 
The LF to HF power ratio was used as an indicator of the 
balance between sympathetic and parasympathetic mod-
ulation of the heart rate.
The time-domain parameters SDNN, SDNNindex, 
SDANN, RMSSD, pNN50, SD1 and SD2 were also cal-
culated. SDNN is the standard deviation of all NN inter-
vals. SDANN is the standard deviation of the consecutive 
5-min averages of NN intervals. SDNNindex is the mean 
of the 5-min standard deviation of the NN intervals. 
RMSSD is the root mean square of successive differences 
of NN intervals. pNN50 is the proportion of differences 
in consecutive NN intervals >50 ms divided by the total 
number of NN intervals. SD1 and SD2 are scatterplots of 
each R–R interval against the preceding R–R interval and 
Poincaré plots were constructed [21]. SD1 and SD2 are 
two time-domain parameters calculated from Poincaré 
plots, i.e., scatterplots of each R–R interval against the 
consecutive value and are measures of the standard devi-
ation in two perpendicular directions in the plots. SD1 
describes the magnitude of the beat-to-beat variability, 
reflecting vagal modulation of HRV and is strongly corre-
lated with the HF spectral component. SD2, on the other 
hand, describes the fluctuations in mean R–R interval 
over the 24-h period. Data on SD1 and SD2 are presented 
in Table 3. Calculations were performed using the Matlab 
Software (MathWorks, Natick, Mass., USA).
Blood chemistry
Blood glucose concentrations were determined by 
HemoCue glucose system (HemoCue AB, Ängelholm, 
Sweden) and HbA1c by high-pressure liquid chromatog-
raphy (HPLC) (Integral 4000, BioRad, Anaheim, Califor-
nia, USA). Serum insulin concentrations were measured 
by micro particle immuno assay (MEIA) (Abbot Imx, 
Abbot Laboratories, Abbot Park, Illinois, USA). All other 
analyses of blood chemistry were performed according to 
routine methods at the Department of Clinical Chemis-
try, Umeå University Hospital.
Statistical methods
Data are mean ± SD or as indicated. Differences between 
groups were tested using Students unpaired t test. Analy-
ses of data from the short-term HRV examination were 
performed using ANOVA of repeated measurements. 
Analysis of variance (ANCOVA) with age as covari-
ate was used to analyse data from the long-term HRV 
examination. Intergroup comparisons were performed 
by including a binary variable in the ANCOVA, whereas 
the relation between HRV and IR was investigated by 
including the M value as covariate in the ANCOVA. 
Univariate regression analyses were utilised to demon-
strate associations between M value and long-term HRV 
parameters. Long-term HRV parameters that were near-
significantly associated with M value in the univariate 
analyses (p  ≤  0.1) were included in multivariate analy-
ses one by one adjusting for age and body composition 
(as indicated) (see Table  3 and Additional file  1: Table 
S3). Multivariate regression analyses (the enter statis-
tics in SPSS) were used to assess independent relation-
ships between M value, age and body composition, and 
long-term HRV parameters. p values less than 0.05 were 
considered as statistically significant. Statistical analyses 
were performed using the SPSS software package version 
18 (SPSS Inc., Chicago, IL).
Results
T2D relatives (R) and control subjects (C)
T2D relatives (R) and control subjects (C) groups were 
matched for sex, age and BMI as shown in Table 1. There 
were no significant differences between the groups except 
that the 2-h blood glucose levels during OGTT was 
slightly higher in R (p = 0.049). No differences in the Eve-
ryday Life Stress Scale instrument were found between R 
and C and there was no association between IR and level 
of self-rated stress behaviour overall (not shown). During 
the short-term HRV assessments, there was a tendency 
towards a higher LF to HF power ratio in R (Additional 
file 1: Table S1). During the 24-h ECG recordings the fre-
quency domain indices age-adjusted total spectral power, 
VLF power and SD1 were significantly lower in R com-
pared to C as displayed in Table 2 and illustrated in Fig. 1, 
where one of the control subjects (C), to the left, displays 
a normal HRV compared to a T2D relative (R) who has a 
reduced HRV. In parallel, the time domain indices SDNN, 
SDNNindex, RMSSD and pNN50 were also significantly 
lower in R compared to C as displayed in Table 2.
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Short‑term heart rate variability, insulin sensitivity 
and body composition
In the short-term HRV examination M value was 
significantly associated to LF to HF power ratio 
(p  =  0.007). In univariate regression analyses for 
each part of the short-term HRV examination there 
were significant and positive associations between M 
value and HF power, normalised LF power and LF to 
HF power ratio during the cold pressor test (r = 0.33, 
p  =  0.036, r  =  −0.35, p  =  0.0.26 and r  =  −0.37 
p =  0.019). In univariate analyses of short-term HRV 
in all subjects VAT was inversely associated with total 
and HF power both in the basal state (r  =  −0.38, 
p = 0.014 and r = −0.420, p = 0.007) and during con-
trolled breathing (r = −0.43, p = 0.006 and r = −0.46, 
p  =  0.003). SAT was inversely associated with HF 
power (r  =  −0.36, p  =  0.023) and near-significantly 
with total and LF power during controlled breathing 
(r = −0.30, p = 0.06 and r = −0.28, p = 0.08, respec-
tively). BMI was inversely significantly associated with 
HF power during controlled breathing (r  =  −0.35, 
p = 0.023).
Table 1 Clinical and biochemical characteristics of type 2 diabetes relatives (R) and control subjects (C)
Data are means (sd) or number of subjects
HU hounsfield units
a Only subjects participating in the CT examination (n = 44; 21 R. 23 C)
b Calculated values obtained from the CT scans at the L2 and L4 levels






Sex (m/f ) 12/11 13/11 n.s.
Age (years) 46.8 (12.0) 47.2 (11.7) n.s.
BMI (kg/m2) 25.1 (3.8) 25.0 (3.1) n.s.
Weight (kg) 78.4 (16.4) 77.5 (15.1) n.s
Waist (cm) 88.6 (12.0) 88.2 (11.5) n.s.
Waist/hip ratio 0.86 (0.09) 0.85 (0.09) n.s.
Heart rate at rest (beats/min) 65.7 (8.1) 66.3 (7.5) n.s.
Systolic blood pressure (mmHg) 118 (18) 113 (11) n.s.
Diastolic blood pressure (mmHg) 77 (12) 79 (13) n.s.
Smokers/non-smokers 1/22 3/24 n.s.
Fat mass (%) 28.2 (7.2) 28.8 (7.3) n.s.
Visceral adipose tissue (VAT, cm2)a,b 94.1 (56.4) 101.5 (56.2) n.s.
Subcutaneous adipose tissue (SAT, cm2)a,b 204.4 (75.0) 220.0 (83.1) n.s.
Visceral/subcutaneous adipose tissue ratioa,b 0.48 (0.28) 0.49 (0.28) n.s.
Liver fat content (Mean HU) 66.0 (6.4) 64.2 (5.9) n.s.
HbA1c (IFCC; mmol/mol)c 34.1 (4.0) 33.7 (8.0) n.s.
Fasting blood glucose (mmol/L) 5.5 (0.6) 5.5 (0.5) n.s.
Fasting serum insulin (mU/L) 7.5 (6.9) 6.9 (3.6) n.s.
HOMA IR 1.8 (11.7) 1.7 (50.9) n.s.
HOMA β % 81.0 (69.5) 80.1 (41.2) n.s.
OGTT 2 h blood glucose (mmol/L) 7.3 (1.3) 6.5 (1.3) 0.049
Serum cholesterol (mmol/L) 5.1 (0.9) 5.2 (0.9) n.s.
Serum HDL-cholesterol (mmol/L) 1.36 (0.38) 1.50 (0.43) n.s.
Serum LDL-cholesterol (mmol/L) 3.2 (0.9) 3.2 (0.8) n.s.
Serum triglycerides (mmol/L) 1.21 (0.73) 1.07 (0.39) n.s.
M value (mg/kg lean body mass/min) 12.4 (5.0) 13.2 (4.5) n.s.
Mean serum insulin during clamp (mU/L) 92.9 (31.4) 94.6 (22.0) n.s.
Insulin sensitivity index (ISI) [(100 × mg/kg/(mU/L)] 15.0 (7.2) 15.0 (7.0) n.s
Plasma NEFA (µmol/L)
 Basal 0.28 (0.10) 0.33 (0.11) 0.09
 During clamp 0.03 (0.05) 0.02 (0.01) n.s.
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Long‑term heart rate variability, insulin sensitivity 
and body composition
In all subjects the M value was negatively and signifi-
cantly associated with BMI (r = −0.54, p < 0.001), sub-
cutaneous (SAT) (r  =  −0.39, p  =  0.009) and visceral 
adipose tissue (VAT) (r = −0.43, p = 0.004) but not with 
the amount of liver fat (r = 0.22, p = 0.14).
HF power and LF to HF power ratio in long-term HRV 
were significantly associated with M value (r  =  0.30, 
p  =  0.047 and r  =  −0.41, p  =  0.005, respectively) and 
the inverse and significant association between LF to HF 
power ratio and M value is also displayed in Fig. 2. In addi-
tion, LF to HF power ratio was inversely associated with 
age (r  =  −0.40, p  =  0.006) (not shown). HF power and 
SD1 were also significantly or near-significantly associated 
with M value in univariate analyses (r =  0.30, p =  0.047 
and r  =  0.29, p  =  0.052, respectively) (Additional file  1: 
Table S2). We also evaluated the correlation between time- 
and frequency-domain variables in long-term HRV and 
a strong correlation was found between the power of the 
HF component and RMSSD (r2 = 0.88) and Ptot and SDN-
Nindex (r2 = 0.94), respectively (not shown).
In a multivariate model BMI and LF to HF power 
ratio in long-term HRV but not age were significantly 
and independently associated with M value (r2  =  0.33, 
p =  0.001 for model, std β = −0.46, p  <  0.001 and std 
β = −0.29, p = 0.04 and std β = 0.03, p = 0.81, respec-
tively) (Table 3). When VAT was entered instead of BMI 
the model displayed a lower r2 (r2 = 0.26, p = 0.007 for 
model) but VAT and long-term LF to HF power ratio still 
remained significantly or near-significantly and indepen-
dently associated with M value (std β = −0.35, p = 0.029 
and std β = −0.31, of p = 0.054, respectively) (Table 3). 
Similar multivariate models using SD1 and HF power 
from long-term HRV were calculated but together they 
displayed a lower r2, and thus HF power and SD1 did not 
contribute significantly in the models (Additional file  1: 
Table S4). In summary, the best model to explain M value 
included BMI and LF to HF power ratio (std β = −0.46, 
p  =  0.001 and std β  =  −0.28, p  =  0.003; r2  =  0.37, 
p < 0.001 for model).
Short‑term heart rate variability (HRV) and change 
in insulin sensitivity over time
Seven subjects had longitudinal data on short-term HRV 
and M value available at two time points mean 6  years 
apart. In these subjects, a high LF to HF power ratio at 
baseline was significantly associated with reduction in M 
value over time (r = −0.82, p = 0.024).
Discussion
In the present study we show an association between 
insulin resistance and altered balance between sym-
pathetic and parasympathetic nervous activity using 
long-term ECG registrations. In addition, we show dif-
ferences in ANS balance between healthy subjects with 
either two first-degree or one first-degree plus at least 
two second-degree relatives with T2D (T2D relatives) 
and subjects without a history of T2D.
IR occurs early in the development of T2D and has 
been demonstrated already in healthy T2D relatives [1]. 
Previous studies have suggested that alteration of ANS 
activity is associated with and important for IR in  vivo 
[6]. The findings in this study are in line with similar 
results obtained using short-term HRV assessments [9, 
24] but this time was shown using long-term HRV assess-
ments analysing indices from 24-h ECG-recordings.
Significant associations between IR (M value) and LF to 
HF power ratio in both short-term and long-term HRV 
Table 2 Heart rate variability (HRV) frequency-, time- 
and  poincaré parameters from  the long-term 24-h ECG 
recordings during everyday life and daily activities in T2D 
relatives (n = 21) and control subjects (n = 21)
Five subjects missing, see methods section. Values are mean values and standard 
deviation (sd). Spectral indices are log-transformed. p values are derived from a 
comparison of relatives and controls analysis of variance (ANCOVA) of repeated 
measurements, adjusting for age. HRV heart rate variability, Ptot total power, 
PVLF power of very low frequency component, PLF power of low frequency 
component, PHF power of high frequency component, PLF/PHF power of low 
frequency/power of high frequency ratio, SDNN is the standard deviation of all 
NN intervals, SDANN is the standard deviation of the consecutive 5-min averages 
of NN intervals, SDNNindex is the mean of the 5-min standard deviation of the 
NN intervals, RMSSD is the root mean square of successive differences of NN 
intervals, pNN50 is the proportion of differences in consecutive NN intervals 
>50 ms divided by the total number of NN intervals, SD1 and SD2 are two time-
domain parameters calculated from Poincaré plots, i.e., scatterplots of each 
R–R interval against the consecutive value, SD1 describes the magnitude of the 









2, log) 3.50 (0.16) 3.61 (0.25) 0.02
 PVLF (ms
2, log) 3.28 (0.15) 3.38 (0.21) 0.03
 PLF (ms
2, log) 2.96 (0.23) 3.06 (0.32) 0.09
 PHF (ms
2, log) 2.47 (0.28) 2.58 (0.43) 0.10
 PLF/PHF (log) 0.49 (0.17) 0.48 (0.26) 0.74
Time domain indices
 SDNN 151 (24) 169 (45) 0.09
 SDANN (ms) 137.8 (25.8) 150.7 (42.3) 0.21
 SDNNindex 60.9 (11.0) 72.1 (21.4) 0.008
 RMSSD (ms) 34.0 (11.3) 44.8 (22.1) 0.02
 pNN50 (%) 10.0 (5.75) 16.2 (11.7) 0.006
Poincaré indices
 SD1 (ms) 22.9 (6.7) 29.2 (13.8) 0.01
 SD2 (ms) 212 (34) 235 (61) 0.09
 SD1/SD2 0.11 (0.03) 0.12 (0.04) 0.08
 RR interval (s) (average heart rate) 0.78 (0.08) 0.83 (0.08) 0.06
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imply and support that an imbalance in ANS regulation 
may play a role in IR. These associations remained sig-
nificant or near-significant also after adjusting for both 
age and different aspects of body composition. The role 
of ANS dysregulation in the development of IR was fur-
ther supported by a small subgroup analysis of seven 
subjects with available longitudinal data on HRV in 
whom LF to HF power ratio at baseline was significantly 
associated with change in insulin sensitivity (M value) 
during the following 6  years. An imbalance in the ANS 
could be explained by a combination of a relative increase 
in sympathetic activation as well as an attenuation of 
parasympathetic activity and could therefore be in line 
with previous findings that IR is associated with both a 
parasympathetic dysfunction as well as an enhanced 
sympathetic reactivity [25].
In the present study differences in HRV between T2D 
relatives and controls were more pronounced in long-
term than the short-term assessments suggesting that 
other mechanisms, such as physical activity and other 
life-style factors also may be of importance [25]. In addi-
tion, age-adjusted total and very low frequency (VLF) 
power was significantly lower in T2D relatives indicating 
that reduced vagal activation potentially could be an early 
component in the development of T2D [26].
Obesity, perhaps via relative hyperinsulinemia, could 
be an additional link between IR and ANS activity since 
sympathetic activity is related to the degree of adiposity 
Fig. 1 Long-term heart rate variability (HRV) using 24-h ECG recordings in two subjects where the subject to the right (a control) presented higher 
heart rate variability compared to the subject shown to the left (b). Top panels show the total average power spectrum and the bottom panels show 
Poincaré plots where each point shows the relation between two subsequent RR intervals. 24 h PSD = average power spectral density over 24-h, 
RR(x) = “current” RRinterval, RR(x−1) = previous RR-interval
Page 7 of 9Svensson et al. Cardiovasc Diabetol  (2016) 15:91 
[8]. Our present study, in combination with previous 
work [8], support that obesity, and in particular visceral 
obesity, leads to dysregulated ANS activity, which in turn 
contributes to IR. However, somewhat surprisingly, acute 
pharmacological inhibition of vagal signals enhance 
insulin sensitivity in a previous study from our group 
[27]. Therefore it could be hypothesized that acute and 
chronic effects of the ANS could have differential impact 
on glucose metabolism. The finding that dietary interven-
tion in obese subjects was followed by an increase in both 
vagal function and insulin sensitivity [28] also supports 
that IR may be modifiable by changes in the ANS.
The association between IR and visceral adiposity is 
well established [29, 30]. In this study VAT was asso-
ciated with an increase in LF to HF power ratio and 
decreased HF power. When adjusting for VAT in analy-
sis of short-term HRV parameters, only LF power and LF 
to HF power ratio during controlled breathing remained 
significantly associated with insulin sensitivity poten-
tially indicating that IR is potentially more associated 
with parasympathetic dysregulation and visceral adi-
posity than sympathetic regulation. However, this study 
showed that models including BMI together with long-
term HRV indices had the strongest association with IR 
indicating that total adiposity potentially may promote 
IR via an indirect increase in sympathetic/parasympa-
thetic balance, for example via high FFA levels reaching 
the hypothalamus [31]. A recent report also showed that 
direct SNS innervation of adipocytes that can stimulate 
lipolysis [32], and thus possibly contributing to IR via 
elevated FFA levels [33]. Other factors like inflammation 
and leptin could be additional links between IR and ANS 
activity as indicated form other larger cohort studies [34, 
35]. Another suggested link between IR and alterations in 
ANS activity, namely hyperinsulinemia, could potentially 
also be a link to hypertension, dyslipidemia and develop-
ment of cardiovascular disease [36].
Life style factors, including stress, may also be of 
importance and it is therefore interesting that pro-
nounced differences in HRV were found between the 
T2D relatives and controls analysing the 24-h ECG-
recordings during normal activities supporting an atten-
uation of the parasympathetic activity in T2D relatives 
when compared to control subjects. Since no significant 
differences in metabolic parameters, body composition 
or the Everyday Life Stress Scale instrument were found 
between the two groups this may suggest an underlying 
(epi) genetic difference in autonomic nerve activity that 
precedes development of IR. This is in agreement with 
clinical longitudinal studies [37, 38].
Many of the time- and frequency-domain variables 
measured over the entire 24 h period are strongly corre-
lated with each other [39]. The advantage of frequency-
domain analysis, as used in this study, is the association 
between spectral components and the activity in the 
specific parts of the autonomic system. LF to HF power 
ratio, considered to reflect sympathetic nerve activity, 
cannot be assessed using time-domain analyses.
A weakness of our study is that no formal power cal-
culation was performed and that the study has limited 
Fig. 2 Long-term heart rate variability (HRV) assessed by 24-h ECG 
recordings. LF to HF power ratio was negatively and significantly 
associated with M value (mg/kg lbm/min) inrelatives (R = blue circles) 
and controls (C = green triangles) taken together
Table 3 Results from  multiple linear regression analyses 
with  insulin resistance (M value) as  dependent variable 
and  body composition (BMI or VAT), age, and  LF-to-HF 
power ratio during long-term HRV entered as independent 
variables
Spectral indices are log-transformed. Age and body composition (BMI or VAT) 
were entered as independent variables
HRV heart rate variability, LF to HF power ratio ration between power of the low 




Independent variables Std β p value
M value BMI −0.46 0.001
Age 0.03 0.81
Long-term LF to HF power ratio −0.29 0.040
M value VAT −0.35 0.029
Age 0.06 0.04
Long-term LF to HF power ratio −0.31 0.054
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power in analysing the relationship between IR and 
activity of the ANS. It must also be appreciated that the 
activity of the ANS was only examined at the level of the 
heart, which might differ from the ANS activity in other 
organs crucial for insulin action such as liver, muscle and 
adipose tissue.
In conclusion, the present study shows that indices of 
heart rate variability during everyday life are associated 
with insulin sensitivity, and it suggests that a higher ratio 
of sympathetic to parasympathetic autonomic nerve 
activity promotes insulin resistance. Longitudinal data 
from a subgroup analysis support that such an imbalance 
in the ANS may precede development of insulin resist-
ance. Moreover, first-degree relatives of type 2 diabe-
tes patients had reduced total heart rate variability and 
an elevated heart rate suggesting that certain genetic 
or epigenetic factors may contribute both to dysregula-
tion of ANS and potentially to the development of type 2 
diabetes.
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